Cargando…

Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors

BACKGROUND: Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC). METHODS: In a series of 316 EC sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Yoshinori, Makino, Tomoki, Sato, Eiichi, Ohshima, Kenji, Nogi, Yuya, Kanemura, Takashi, Honma, Keiichiro, Yamashita, Kotaro, Saito, Takuro, Tanaka, Koji, Yamamoto, Kazuyoshi, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Miyata, Hiroshi, Nakajima, Kiyokazu, Wada, Hisashi, Morii, Eiichi, Eguchi, Hidetoshi, Doki, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241865/
https://www.ncbi.nlm.nih.gov/pubmed/37016103
http://dx.doi.org/10.1038/s41416-023-02235-9
_version_ 1785054084417454080
author Hayashi, Yoshinori
Makino, Tomoki
Sato, Eiichi
Ohshima, Kenji
Nogi, Yuya
Kanemura, Takashi
Honma, Keiichiro
Yamashita, Kotaro
Saito, Takuro
Tanaka, Koji
Yamamoto, Kazuyoshi
Takahashi, Tsuyoshi
Kurokawa, Yukinori
Miyata, Hiroshi
Nakajima, Kiyokazu
Wada, Hisashi
Morii, Eiichi
Eguchi, Hidetoshi
Doki, Yuichiro
author_facet Hayashi, Yoshinori
Makino, Tomoki
Sato, Eiichi
Ohshima, Kenji
Nogi, Yuya
Kanemura, Takashi
Honma, Keiichiro
Yamashita, Kotaro
Saito, Takuro
Tanaka, Koji
Yamamoto, Kazuyoshi
Takahashi, Tsuyoshi
Kurokawa, Yukinori
Miyata, Hiroshi
Nakajima, Kiyokazu
Wada, Hisashi
Morii, Eiichi
Eguchi, Hidetoshi
Doki, Yuichiro
author_sort Hayashi, Yoshinori
collection PubMed
description BACKGROUND: Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC). METHODS: In a series of 316 EC surgical specimens from two different institutes, we evaluated the density and maturity of peritumoral TLSs using haematoxylin/eosin, immunohistochemistry, and multiplex immunofluorescence staining. We analysed the association between TLSs and clinicopathological parameters. The clinical significance of TLSs was further evaluated in a different cohort of 34 patients with recurrent EC treated with anti-PD-1 antibody. RESULTS: Tumours with high TLS density predominantly consisted of matured TLSs. High TLS density was significantly associated with less advanced tumour stage, absence of lymphatic/vascular invasion, better serum nutrition parameters (neutrophils count, albumin, neutrophil-to-lymphocyte ratio, and prognostic nutritional index), and prolonged survival. This survival trend was more remarkable in cases with matured TLSs, which represented an increased population of CD138(+) plasma cells. In the second EC cohort, TLS density predicted the clinical response to anti-PD-1 antibody and patient survival. CONCLUSION: The density and maturity of peritumoral TLSs are useful parameters for predicting long-term survival and response to anti-PD-1 antibody treatment in EC patients.
format Online
Article
Text
id pubmed-10241865
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102418652023-06-07 Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors Hayashi, Yoshinori Makino, Tomoki Sato, Eiichi Ohshima, Kenji Nogi, Yuya Kanemura, Takashi Honma, Keiichiro Yamashita, Kotaro Saito, Takuro Tanaka, Koji Yamamoto, Kazuyoshi Takahashi, Tsuyoshi Kurokawa, Yukinori Miyata, Hiroshi Nakajima, Kiyokazu Wada, Hisashi Morii, Eiichi Eguchi, Hidetoshi Doki, Yuichiro Br J Cancer Article BACKGROUND: Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC). METHODS: In a series of 316 EC surgical specimens from two different institutes, we evaluated the density and maturity of peritumoral TLSs using haematoxylin/eosin, immunohistochemistry, and multiplex immunofluorescence staining. We analysed the association between TLSs and clinicopathological parameters. The clinical significance of TLSs was further evaluated in a different cohort of 34 patients with recurrent EC treated with anti-PD-1 antibody. RESULTS: Tumours with high TLS density predominantly consisted of matured TLSs. High TLS density was significantly associated with less advanced tumour stage, absence of lymphatic/vascular invasion, better serum nutrition parameters (neutrophils count, albumin, neutrophil-to-lymphocyte ratio, and prognostic nutritional index), and prolonged survival. This survival trend was more remarkable in cases with matured TLSs, which represented an increased population of CD138(+) plasma cells. In the second EC cohort, TLS density predicted the clinical response to anti-PD-1 antibody and patient survival. CONCLUSION: The density and maturity of peritumoral TLSs are useful parameters for predicting long-term survival and response to anti-PD-1 antibody treatment in EC patients. Nature Publishing Group UK 2023-04-04 2023-06-29 /pmc/articles/PMC10241865/ /pubmed/37016103 http://dx.doi.org/10.1038/s41416-023-02235-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hayashi, Yoshinori
Makino, Tomoki
Sato, Eiichi
Ohshima, Kenji
Nogi, Yuya
Kanemura, Takashi
Honma, Keiichiro
Yamashita, Kotaro
Saito, Takuro
Tanaka, Koji
Yamamoto, Kazuyoshi
Takahashi, Tsuyoshi
Kurokawa, Yukinori
Miyata, Hiroshi
Nakajima, Kiyokazu
Wada, Hisashi
Morii, Eiichi
Eguchi, Hidetoshi
Doki, Yuichiro
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
title Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
title_full Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
title_fullStr Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
title_full_unstemmed Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
title_short Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
title_sort density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241865/
https://www.ncbi.nlm.nih.gov/pubmed/37016103
http://dx.doi.org/10.1038/s41416-023-02235-9
work_keys_str_mv AT hayashiyoshinori densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT makinotomoki densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT satoeiichi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT ohshimakenji densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT nogiyuya densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT kanemuratakashi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT honmakeiichiro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT yamashitakotaro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT saitotakuro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT tanakakoji densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT yamamotokazuyoshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT takahashitsuyoshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT kurokawayukinori densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT miyatahiroshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT nakajimakiyokazu densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT wadahisashi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT moriieiichi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT eguchihidetoshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors
AT dokiyuichiro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors